Ascelia Pharma AB (OSTO:ACE) Other Long Term Assets : kr-0.00 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Ascelia Pharma AB Other Long Term Assets?

Ascelia Pharma AB's other long-term assets for the quarter that ended in Dec. 2023 was kr-0.00 Mil.

Ascelia Pharma AB's quarterly other long-term assets declined from Jun. 2023 (kr0.00 Mil) to Sep. 2023 (kr-0.00 Mil) but then stayed the same from Sep. 2023 (kr-0.00 Mil) to Dec. 2023 (kr-0.00 Mil).

Ascelia Pharma AB's annual other long-term assets declined from Dec. 2021 (kr0.00 Mil) to Dec. 2022 (kr-0.00 Mil) and declined from Dec. 2022 (kr-0.00 Mil) to Dec. 2023 (kr-0.00 Mil).

Ascelia Pharma AB Other Long Term Assets Historical Data

The historical data trend for Ascelia Pharma AB's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascelia Pharma AB Other Long Term Assets Chart

Ascelia Pharma AB Annual Data

Trend

Jun17

Jun18

Jun19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

Ascelia Pharma AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial															-	-	-	-	-

Ascelia Pharma AB Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Ascelia Pharma AB (OSTO:ACE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascelia Pharma AB (OSTO:ACE) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

7ZA:Germany

Address

Hyllie Boulevard 34, Malmo, SWE, SE-215 32

Website

https://www.ascelia.com

Ascelia Pharma AB is an oncology-dedicated drug development company located in Malmo, Sweden, focused on the development of novel drugs to improve the life expectancy and quality of life for people living with cancer. The company is focused on two clinical-stage product candidates under development: Mangoral and Oncoral.

Ascelia Pharma AB (OSTO:ACE) Headlines

No Headlines